Menu

FLICKR, TONY WEBSTER

Fresh Concerns Raised About UIC Researcher’s Pediatric Drug Study

New documents reveal that Mani Pavuluri had enrolled her sons as controls in a prematurely halted drug trial, a ProPublica investigation finds.

Jul 3, 2018
Catherine Offord

Emails and other documents recently obtained by ProPublica Illinois have prompted fresh criticism of a famous pediatric psychiatrist whose work violated research rules and put children’s health at risk. University of Illinois at Chicago (UIC) researcher Mani Pavuluri, founder of a clinic to treat children with bipolar disorder, had enrolled her own sons as healthy controls in a clinical study of the therapeutic effects of lithium, ProPublica and The Chronicle of Higher Education report today (July 3).

There are ethical concerns about parents working with their own children in this way, “particularly [in] research that might be quite stressful for a child,” Michael Carome, a former senior official at the US Department of Health and Human Services (HHS) Office for Human Research Protections, tells ProPublica. “At a minimum, the researcher should not have done that without seeking approval from the [university’s institutional review board].”

Pavuluri’s study began in 2009 to examine the effects of lithium on children with biopolar disorder. It was closed down in 2013 after one of those children became ill. A ProPublica Illinois investigation published earlier this year revealed that Pavuluri had seriously violated research practices by testing the drug on children younger than 13—something she was not allowed to do according to study procedure—and falsifying data to cover up the misconduct.

In December 2017, UIC agreed to repay more than $3 million in grant money to the National Institute of Mental Health, which funded Pavuluri’s work. She officially resigned last Saturday (June 30), and her research is currently being examined in two separate investigations related to fraud and research integrity by the HHS.

The new records also reveal that parents of at least eight children contacted the university after finding out about Pavuluri’s conduct. That information appears to conflict with earlier university statements that it had received just one complaint—a letter sent on behalf of a study subject regarding malpractice.

“I was telling them my child was harmed by this study,” a parent who had separately contacted the university, tells ProPublica. She wanted the university “to know that there was a negative impact on my child,” she says. “To me, that is a complaint.”

In an emailed response to ProPublica, a UIC official cites the third of three definitions of “complaint” in an online dictionary as justification for not including this parent’s comments in its count: “The University interpreted your use of the word complaint consistent with the definition of the word found in Merriam Webster Dictionary (online version): ‘a formal allegation against a party.’” 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.